Uso de estatinas em idosos

Sarah Hilmer Danijela Gnjidic


Segurança de medicamentos, estatinas, uso racional de medicamentos

Texto completo:



Morgan TK, Williamson M, Pirotta M, Stewart K, Myers

SP, Barnes J. A national census of medicines use:

a 24-hour snapshot of Australians aged 50 years and

older. Med J Aust 2012;196:50-3.

Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum

cholesterol levels and mortality risk as a function of age.

A report based on the Framingham data. Arch Intern

Med 1993;153:1065-73.

Lewington S , Whitlock G, Clarke R, Sherliker P, Emberson

J, Halsey J, et al. Blood cholesterol and vascular

mortality by age, sex, and blood pressure: a meta-analysis

of individual data from 61 prospective studies with

,000 vascular deaths. Lancet 2007;370:1829-39.

Afilalo J, Duque G, Steele R, Jukema JW, De Craen

AJ, Eisenberg MJ. Statins for secondary prevention in

elderly patients: a hierarchical Bayesian meta-analysis. J

Am Coll Cardiol 2008;51:37-45.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck

G, Pollicino C, et al. Efficacy and safety of cholesterollowering

treatment: prospective meta-analysis of data

from 90,056 participants in 14 randomised trials of

statins. Lancet 2005;366:1267-78.

Lacroix AZ, Gray SL, Aragaki A, Cochrane BB, Newman

AB, Kooperberg CL, et al. Statin use and incident

frailty in women aged 65 years or older: prospective findings

from the Women’s Health Initiative Observational

Study. J Gerontol A Biol Sci Med Sci 2008;63:369-75.

Gnjidic D, Le Couteur DG, Blyth FM, Travison T, Rogers

K, Naganathan V, et al. Statin use and clinical outcomes

in older men: a prospective population-based

study. BMJ Open 2013;3:e002333.

McGuinness B, Craig D, Bullock R, Passmore P.

Statins for the prevention of dementia. Cochrane Database

Syst Rev 2009;2:CD003160.

McGuinness B, O’Hare J, Craig D, Bullock R, Malouf

R, Passmore P. Statins for the treatment of dementia.

Cochrane Database Syst Rev 2010;8:CD007514.

Padala KP, Padala PR, McNeilly DP, Geske JA, Sullivan

DH, Potter JF. The effect of HMG-CoA reductase

inhibitors on cognition in patients with Alzheimer’s dementia:

a prospective withdrawal and rechallenge pilot

study. Am J Geriatr Pharmacother 2012;10:296-302.

Law MR, Wald NJ, Rudnicka AR. Quantifying effect

of statins on low density lipoprotein cholesterol, ischaemic

heart disease, and stroke: systematic review and

meta-analysis. BMJ 2003;326:1423.

Zhou Z, Rahme E, Abrahamowicz M, Tu JV, Eisenberg

MJ, Humphries K, et al. Effectiveness of statins for

secondary prevention in elderly patients after acute

myocardial infarction: an evaluation of class effect.

CMAJ 2005;172:1187-94.

Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy

SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical

advisory on the use and safety of statins. Circulation


Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM,

De Craen AJ, et al. Statins and risk of incident diabetes:

a collaborative meta-analysis of randomized statin trials.

Lancet 2010;375:735-42.

Evans MA, Golomb BA. Statin-associated adverse

cognitive effects: survey results from 171 patients. Pharmacotherapy


King DS, Wilburn AJ, Wofford MR, Harrell TK, Lindley

BJ, Jones DW. Cognitive impairment associated

with atorvastatin and simvastatin. Pharmacotherapy


Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy

PM. Statin-associated memory loss: analysis of 60 case

reports and review of the literature. Pharmacotherapy


Golomb BA, Evans MA, Dimsdale JE, White HL. Effects

of statins on energy and fatigue with exertion:

results from a randomized controlled trial. Arch Intern

Med 2012;172:1180-2.


  • Não há apontamentos.